Your browser doesn't support javascript.
loading
Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'Ivoire.
Ouattara, Eric N; Ross, Eric L; Yazdanpanah, Yazdan; Wong, Angela Y; Robine, Marion; Losina, Elena; Moh, Raoul; Walensky, Rochelle P; Danel, Christine; Paltiel, A David; Eholié, Serge P; Freedberg, Kenneth A; Anglaret, Xavier.
  • Ouattara EN; *Centre Inserm 897, University of Bordeaux, Bordeaux, France; †ISPED, University of Bordeaux, Bordeaux, France; ‡Programme PAC-CI/ANRS Research Site, CHU de Treichville, Abidjan, Côte d'Ivoire; §Division of General Medicine and the Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, MA; ‖Department of Infectious and Tropical Diseases, Bichat-Claude Bernard University Hospital, Paris, France; ¶Equipe Atip/Avenir Inserm U738, University Paris Diderot
J Acquir Immune Defic Syndr ; 66(3): 294-302, 2014 Jul 01.
Article en En | MEDLINE | ID: mdl-24732870
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirrolidinonas / Sulfonamidas / Infecciones por VIH Tipo de estudio: Health_economic_evaluation Límite: Adult / Female / Humans / Male / Middle aged País como asunto: Africa Idioma: En Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirrolidinonas / Sulfonamidas / Infecciones por VIH Tipo de estudio: Health_economic_evaluation Límite: Adult / Female / Humans / Male / Middle aged País como asunto: Africa Idioma: En Año: 2014 Tipo del documento: Article